Psychiatric Mental Health Nurse Practitioner Certification
Exam Version 3 – Advanced Psychiatric Nursing Practice
Questions
1. A 34-year-old patient diagnosed with Schizophrenia presents with auditory hallucinations
and paranoia. Which dopaminergic pathway is primarily associated with these positive
symptoms?
A. Mesocortical pathway
B. Mesolimbic pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
Ans: B
Rationale: The mesolimbic pathway is a dopaminergic tract that projects from the ventral tegmental
area to the nucleus accumbens. In schizophrenia, overactivity in this specific pathway is strongly linked
to the manifestation of positive symptoms such as hallucinations and delusions. Conversely, the
mesocortical pathway is associated with negative symptoms and cognitive impairment when dopamine
levels are low. The nigrostriatal pathway is primarily involved in motor control, and its blockade by
antipsychotics leads to extrapyramidal symptoms. The tuberoinfundibular pathway regulates prolactin
secretion from the pituitary gland. Antipsychotic medications work by blocking D2 receptors in the
mesolimbic tract to reduce psychotic symptoms. Therefore, the correct answer reflects the biological
basis for the patient’s active psychosis. Understanding these pathways is essential for the PMHNP to
predict both therapeutic effects and side effects of medications.
,2. A PMHNP is treating a patient with Lithium for Bipolar I Disorder. Which of the following
laboratory values is the most critical to monitor periodically to avoid toxicity?
A. Complete Blood Count (CBC)
B. Liver Function Tests (ALT/AST)
C. Serum Creatinine and GFR
D. Serum Amylase
Ans: C
Rationale: Lithium is primarily excreted by the kidneys, making renal function monitoring a top priority
for safe prescribing. Serum creatinine and the Glomerular Filtration Rate (GFR) provide essential data on
how well the kidneys are filtering the medication. If renal function declines, lithium levels can rise
rapidly, leading to dangerous toxicity. Symptoms of lithium toxicity include ataxia, coarse tremors, and
confusion, which can progress to seizures or coma. Unlike many other psychiatric medications, lithium is
not metabolized by the liver, so ALT/AST levels are less critical for this specific drug. CBC monitoring is
more relevant for medications like Clozapine or Carbamazepine which carry risks of blood dyscrasias.
The PMHNP must also monitor thyroid function (TSH) because lithium can cause hypothyroidism.
Regular blood draws ensure the patient remains within the narrow therapeutic window of 0.6 to 1.2
mEq/L.
,3. A patient reporting symptoms of depression and anxiety is started on an SSRI. After two
weeks, the patient reports feeling ‘jittery,’ having a fast heartbeat, and experiencing
significant sweating. What is the most likely concern?
A. Neuroleptic Malignant Syndrome
B. Serotonin Syndrome
C. Anticholinergic Crisis
D. Hypertensive Crisis
Ans: B
Rationale: Serotonin syndrome is a potentially life-threatening condition caused by excessive
serotonergic activity in the nervous system. The symptoms described, including tachycardia, diaphoresis,
and agitation, are classic hallmarks of this syndrome. It often occurs when SSRIs are initiated, increased
in dose, or combined with other serotonergic agents. Neuroleptic Malignant Syndrome (NMS) differs
because it is associated with dopamine antagonists and involves severe ‘lead-pipe’ muscle rigidity.
Anticholinergic crisis typically presents with dry skin and mouth, rather than the sweating mentioned in
the scenario. Hypertensive crisis is usually associated with MAOIs and the ingestion of high-tyramine
foods. The PMHNP must immediately assess the patient and likely discontinue the offending agent.
Supportive care and potential administration of benzodiazepines or serotonin antagonists may be
necessary. Recognition of these symptoms is a critical safety competency for advanced practice nurses.
, 4. According to the DSM-5-TR, what is the required minimum duration of symptoms for a
diagnosis of Generalized Anxiety Disorder (GAD)?
A. 1 month
B. 6 months
C. 3 months
D. 12 months
Ans: B
Rationale: The diagnostic criteria for Generalized Anxiety Disorder specify that excessive anxiety and
worry must occur more days than not for at least 6 months. This worry must be related to a number of
events or activities, such as work or school performance. Brief periods of anxiety do not meet the
threshold for GAD, as the condition is characterized by its chronic nature. Patients with GAD often find it
difficult to control the worry and experience physical symptoms like restlessness or muscle tension. One
month of symptoms might point toward an Adjustment Disorder or Panic Disorder depending on the
presentation. Three months is a common threshold for other conditions, but not specifically for the
formal diagnosis of GAD. The 12-month requirement is often seen in certain pediatric behavioral
disorders but is not the standard for adult anxiety. Accurately applying these timeframes is vital for
differential diagnosis in psychiatric practice.
Exam Version 3 – Advanced Psychiatric Nursing Practice
Questions
1. A 34-year-old patient diagnosed with Schizophrenia presents with auditory hallucinations
and paranoia. Which dopaminergic pathway is primarily associated with these positive
symptoms?
A. Mesocortical pathway
B. Mesolimbic pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
Ans: B
Rationale: The mesolimbic pathway is a dopaminergic tract that projects from the ventral tegmental
area to the nucleus accumbens. In schizophrenia, overactivity in this specific pathway is strongly linked
to the manifestation of positive symptoms such as hallucinations and delusions. Conversely, the
mesocortical pathway is associated with negative symptoms and cognitive impairment when dopamine
levels are low. The nigrostriatal pathway is primarily involved in motor control, and its blockade by
antipsychotics leads to extrapyramidal symptoms. The tuberoinfundibular pathway regulates prolactin
secretion from the pituitary gland. Antipsychotic medications work by blocking D2 receptors in the
mesolimbic tract to reduce psychotic symptoms. Therefore, the correct answer reflects the biological
basis for the patient’s active psychosis. Understanding these pathways is essential for the PMHNP to
predict both therapeutic effects and side effects of medications.
,2. A PMHNP is treating a patient with Lithium for Bipolar I Disorder. Which of the following
laboratory values is the most critical to monitor periodically to avoid toxicity?
A. Complete Blood Count (CBC)
B. Liver Function Tests (ALT/AST)
C. Serum Creatinine and GFR
D. Serum Amylase
Ans: C
Rationale: Lithium is primarily excreted by the kidneys, making renal function monitoring a top priority
for safe prescribing. Serum creatinine and the Glomerular Filtration Rate (GFR) provide essential data on
how well the kidneys are filtering the medication. If renal function declines, lithium levels can rise
rapidly, leading to dangerous toxicity. Symptoms of lithium toxicity include ataxia, coarse tremors, and
confusion, which can progress to seizures or coma. Unlike many other psychiatric medications, lithium is
not metabolized by the liver, so ALT/AST levels are less critical for this specific drug. CBC monitoring is
more relevant for medications like Clozapine or Carbamazepine which carry risks of blood dyscrasias.
The PMHNP must also monitor thyroid function (TSH) because lithium can cause hypothyroidism.
Regular blood draws ensure the patient remains within the narrow therapeutic window of 0.6 to 1.2
mEq/L.
,3. A patient reporting symptoms of depression and anxiety is started on an SSRI. After two
weeks, the patient reports feeling ‘jittery,’ having a fast heartbeat, and experiencing
significant sweating. What is the most likely concern?
A. Neuroleptic Malignant Syndrome
B. Serotonin Syndrome
C. Anticholinergic Crisis
D. Hypertensive Crisis
Ans: B
Rationale: Serotonin syndrome is a potentially life-threatening condition caused by excessive
serotonergic activity in the nervous system. The symptoms described, including tachycardia, diaphoresis,
and agitation, are classic hallmarks of this syndrome. It often occurs when SSRIs are initiated, increased
in dose, or combined with other serotonergic agents. Neuroleptic Malignant Syndrome (NMS) differs
because it is associated with dopamine antagonists and involves severe ‘lead-pipe’ muscle rigidity.
Anticholinergic crisis typically presents with dry skin and mouth, rather than the sweating mentioned in
the scenario. Hypertensive crisis is usually associated with MAOIs and the ingestion of high-tyramine
foods. The PMHNP must immediately assess the patient and likely discontinue the offending agent.
Supportive care and potential administration of benzodiazepines or serotonin antagonists may be
necessary. Recognition of these symptoms is a critical safety competency for advanced practice nurses.
, 4. According to the DSM-5-TR, what is the required minimum duration of symptoms for a
diagnosis of Generalized Anxiety Disorder (GAD)?
A. 1 month
B. 6 months
C. 3 months
D. 12 months
Ans: B
Rationale: The diagnostic criteria for Generalized Anxiety Disorder specify that excessive anxiety and
worry must occur more days than not for at least 6 months. This worry must be related to a number of
events or activities, such as work or school performance. Brief periods of anxiety do not meet the
threshold for GAD, as the condition is characterized by its chronic nature. Patients with GAD often find it
difficult to control the worry and experience physical symptoms like restlessness or muscle tension. One
month of symptoms might point toward an Adjustment Disorder or Panic Disorder depending on the
presentation. Three months is a common threshold for other conditions, but not specifically for the
formal diagnosis of GAD. The 12-month requirement is often seen in certain pediatric behavioral
disorders but is not the standard for adult anxiety. Accurately applying these timeframes is vital for
differential diagnosis in psychiatric practice.
